• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION ENVEO PRO DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION ENVEO PRO DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number ENVPRO-14
Device Problem Failure to Advance (2524)
Patient Problem Vascular Dissection (3160)
Event Date 05/13/2022
Event Type  Death  
Manufacturer Narrative
Product analysis: the device was discarded; therefore, no product analysis can be performed.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that during the attempted implant of a transcatheter bioprosthetic valve, via subclavian artery access with a minimum access vessel diameter of 4.9x6.6 millimeter (mm), a dissection of the left axillary artery occurred.Advancement of the delivery catheter system (dcs) was not successful.The dcs was withdrawn from the patient.A graft was placed to address the dissection.Per the physician, the thinner vascular lining in the brachial artery contributed to the dissection.The access site was changed to the left femoral artery with a minimum access diameter of 4.2x6.4mm and was accessed successfully with use of a 14f introducer sheath.The introducer sheath was removed; however, using the same dcs, the femoral artery could not accessed.A left iliac angioplasty was performed with a 7x40mm balloon.The dcs still could not access the left femoral artery.An 18fr introducer sheath was attempted without success.Dissections in the left iliac and left femoral artery were identified.Intervention included the successful placement of covered stents.A valve was not implanted.The patient was returned to the intensive care unit.No adverse patient effects were reported.
 
Manufacturer Narrative
Additional information was received that per the physician, the patient was unstable and the complications from the procedure added to the severity of the case, which lead to the patient's death.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENVEO PRO DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key14566667
MDR Text Key293099995
Report Number2025587-2022-01530
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/07/2023
Device Model NumberENVPRO-14
Device Catalogue NumberENVPRO-14
Device Lot Number0010837780
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/13/2022
Initial Date FDA Received06/01/2022
Supplement Dates Manufacturer Received06/07/2022
Supplement Dates FDA Received06/15/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/07/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Death;
Patient Age87 YR
Patient SexFemale
Patient Weight63 KG
-
-